Annual EBITDA
-$51.22 M
-$18.78 M-57.91%
31 December 2023
Summary:
Orchestra BioMed Holdings annual earnings before interest, taxes, depreciation & amortization is currently -$51.22 million, with the most recent change of -$18.78 million (-57.91%) on 31 December 2023. During the last 3 years, it has fallen by -$29.31 million (-133.81%). OBIO annual EBITDA is now -175.15% below its all-time high of -$18.61 million, reached on 31 December 2020.OBIO EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly EBITDA
-$16.27 M
+$519.00 K+3.09%
30 September 2024
Summary:
Orchestra BioMed Holdings quarterly earnings before interest, taxes, depreciation & amortization is currently -$16.27 million, with the most recent change of +$519.00 thousand (+3.09%) on 30 September 2024. Over the past year, it has dropped by -$3.86 million (-31.08%). OBIO quarterly EBITDA is now -220.20% below its all-time high of -$5.08 million, reached on 31 March 2022.OBIO Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM EBITDA
-$59.81 M
-$1.81 M-3.13%
30 September 2024
Summary:
Orchestra BioMed Holdings TTM earnings before interest, taxes, depreciation & amortization is currently -$59.81 million, with the most recent change of -$1.81 million (-3.13%) on 30 September 2024. Over the past year, it has dropped by -$8.59 million (-16.77%). OBIO TTM EBITDA is now -1077.34% below its all-time high of -$5.08 million, reached on 31 March 2022.OBIO TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
OBIO EBITDA Performance
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | - | -31.1% | -16.8% |
3 y3 years | -133.8% | - | - |
5 y5 years | - | - | - |
OBIO EBITDA High & Low
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3 years | -133.8% | at low | -220.2% | +3.1% | -1077.3% | at low |
5 y | 5 years | -175.2% | at low | -220.2% | +3.1% | -1077.3% | at low |
alltime | all time | -175.2% | at low | -220.2% | +3.1% | -1077.3% | at low |
Orchestra BioMed Holdings EBITDA History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Sept 2024 | - | -$16.27 M(-3.1%) | -$59.81 M(+3.1%) |
June 2024 | - | -$16.79 M(+17.0%) | -$58.00 M(+7.2%) |
Mar 2024 | - | -$14.35 M(+15.6%) | -$54.09 M(+5.6%) |
Dec 2023 | -$51.22 M | -$12.41 M(-14.1%) | -$51.22 M(+5.5%) |
Sept 2023 | - | -$14.45 M(+12.2%) | -$48.57 M(+10.1%) |
June 2023 | - | -$12.88 M(+12.3%) | -$44.13 M(+13.7%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Mar 2023 | - | -$11.47 M(+17.6%) | -$38.80 M(+19.7%) |
Dec 2022 | -$32.44 M(+48.1%) | -$9.76 M(-2.5%) | -$32.40 M(+43.1%) |
Sept 2022 | - | -$10.01 M(+32.6%) | -$22.64 M(+79.3%) |
June 2022 | - | -$7.55 M(+48.6%) | -$12.63 M(+148.6%) |
Mar 2022 | - | -$5.08 M | -$5.08 M |
Dec 2021 | -$21.91 M(+17.7%) | - | - |
Dec 2020 | -$18.61 M | - | - |
FAQ
- What is Orchestra BioMed Holdings annual earnings before interest, taxes, depreciation & amortization?
- What is the all time high annual EBITDA for Orchestra BioMed Holdings?
- What is Orchestra BioMed Holdings quarterly earnings before interest, taxes, depreciation & amortization?
- What is the all time high quarterly EBITDA for Orchestra BioMed Holdings?
- What is Orchestra BioMed Holdings quarterly EBITDA year-on-year change?
- What is Orchestra BioMed Holdings TTM earnings before interest, taxes, depreciation & amortization?
- What is the all time high TTM EBITDA for Orchestra BioMed Holdings?
- What is Orchestra BioMed Holdings TTM EBITDA year-on-year change?
What is Orchestra BioMed Holdings annual earnings before interest, taxes, depreciation & amortization?
The current annual EBITDA of OBIO is -$51.22 M
What is the all time high annual EBITDA for Orchestra BioMed Holdings?
Orchestra BioMed Holdings all-time high annual earnings before interest, taxes, depreciation & amortization is -$18.61 M
What is Orchestra BioMed Holdings quarterly earnings before interest, taxes, depreciation & amortization?
The current quarterly EBITDA of OBIO is -$16.27 M
What is the all time high quarterly EBITDA for Orchestra BioMed Holdings?
Orchestra BioMed Holdings all-time high quarterly earnings before interest, taxes, depreciation & amortization is -$5.08 M
What is Orchestra BioMed Holdings quarterly EBITDA year-on-year change?
Over the past year, OBIO quarterly earnings before interest, taxes, depreciation & amortization has changed by -$3.86 M (-31.08%)
What is Orchestra BioMed Holdings TTM earnings before interest, taxes, depreciation & amortization?
The current TTM EBITDA of OBIO is -$59.81 M
What is the all time high TTM EBITDA for Orchestra BioMed Holdings?
Orchestra BioMed Holdings all-time high TTM earnings before interest, taxes, depreciation & amortization is -$5.08 M
What is Orchestra BioMed Holdings TTM EBITDA year-on-year change?
Over the past year, OBIO TTM earnings before interest, taxes, depreciation & amortization has changed by -$8.59 M (-16.77%)